• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性疾病患者唾液髓过氧化物酶的变化:系统评价。

Salivary Alterations of Myeloperoxidase in Patients with Systemic Diseases: A Systematic Review.

机构信息

Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.

Student's Scientific Group in Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.

出版信息

Int J Mol Sci. 2023 Jul 28;24(15):12078. doi: 10.3390/ijms241512078.

DOI:10.3390/ijms241512078
PMID:37569455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10418962/
Abstract

Salivary myeloperoxidase (MPO) is a key mediator of the oral immune system, acting as an enzyme that utilises HO to generate molecules with high bactericidal activity. While MPO determination in plasma is quite common, the use of saliva is still rare. Our systematic review was designed to answer the question "Are salivary levels of myeloperoxidase altered in patients with systemic diseases?". Following the inclusion and exclusion criteria, we included twenty-six studies. Altered MPO levels in saliva were most commonly found in patients with cardiovascular and gastrointestinal diseases. Most studies concerned unstimulated whole saliva, and only a few of them stimulated, mainly by chewing paraffin. Enzyme-linked immunosorbent assay (ELISA) was the most common method for determination of MPO concentrations in saliva. Increased salivary MPO levels were more often observed for inflammatory diseases, except patients with inflammatory bowel diseases who were eligible for biologic therapy. In conclusion, MPO could be altered in the saliva of patients with systematic diseases, especially cardiovascular or gastrointestinal diseases. However, further investigations are recommended to validate these outcomes.

摘要

唾液髓过氧化物酶 (MPO) 是口腔免疫系统的关键介质,作为一种利用 HO 生成具有高杀菌活性的分子的酶。虽然血浆中 MPO 的测定相当常见,但唾液的使用仍然很少。我们的系统评价旨在回答“系统性疾病患者的唾液髓过氧化物酶水平是否改变?”这个问题。根据纳入和排除标准,我们纳入了 26 项研究。唾液中 MPO 水平的改变在心血管和胃肠道疾病患者中最为常见。大多数研究涉及未刺激的全唾液,只有少数研究是通过咀嚼石蜡来刺激,主要是通过咀嚼石蜡。酶联免疫吸附试验 (ELISA) 是最常用的测定唾液 MPO 浓度的方法。除了有资格接受生物治疗的炎症性肠病患者外,炎症性疾病患者的唾液 MPO 水平升高更为常见。总之,系统性疾病患者的唾液 MPO 可能会发生改变,尤其是心血管疾病或胃肠道疾病患者。然而,建议进一步研究以验证这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a14/10418962/22d423c182bd/ijms-24-12078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a14/10418962/11f9b30159b8/ijms-24-12078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a14/10418962/22d423c182bd/ijms-24-12078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a14/10418962/11f9b30159b8/ijms-24-12078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a14/10418962/22d423c182bd/ijms-24-12078-g002.jpg

相似文献

1
Salivary Alterations of Myeloperoxidase in Patients with Systemic Diseases: A Systematic Review.系统性疾病患者唾液髓过氧化物酶的变化:系统评价。
Int J Mol Sci. 2023 Jul 28;24(15):12078. doi: 10.3390/ijms241512078.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Association Between Cardiovascular Disease and Complete Edentulism in U.S. Adults.美国成年人心血管疾病与全口无牙之间的关联。
J Clin Med. 2025 Aug 26;14(17):6035. doi: 10.3390/jcm14176035.
2
Salivary Lactate Dehydrogenase, Matrix Metalloproteinase-9, and Chemerin-The Most Promising Biomarkers for Oral Cancer? A Systematic Review with Meta-Analysis.唾液乳酸脱氢酶、基质金属蛋白酶-9和凯莫瑞——口腔癌最有前景的生物标志物?一项荟萃分析的系统评价
Int J Mol Sci. 2025 Aug 18;26(16):7947. doi: 10.3390/ijms26167947.
3
Balancing the Oral Redox State: Endogenous and Exogenous Sources of Reactive Oxygen Species and the Antioxidant Role of Lamiaceae and Asteraceae.

本文引用的文献

1
Treatment regimens and disease activity could alter salivary myeloperoxidase levels in patients with inflammatory bowel diseases.治疗方案和疾病活动度可能会改变炎症性肠病患者的唾液髓过氧化物酶水平。
Pol Arch Intern Med. 2024 Jan 29;134(1). doi: 10.20452/pamw.16596. Epub 2024 Jan 2.
2
Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma.髓过氧化物酶抑制可能预防新型冠状病毒肺炎血浆诱导的内皮糖萼脱落。
Commun Med (Lond). 2023 May 5;3(1):62. doi: 10.1038/s43856-023-00293-x.
3
Salivary and serum levels of neutrophil proteases in periodontitis and rheumatoid arthritis.
平衡口腔氧化还原状态:活性氧的内源性和外源性来源以及唇形科和菊科的抗氧化作用。
Dent J (Basel). 2025 May 21;13(5):222. doi: 10.3390/dj13050222.
4
Saliva as a Diagnostic Tool for Systemic Diseases-A Narrative Review.唾液作为全身性疾病的诊断工具——一篇叙述性综述。
Medicina (Kaunas). 2025 Jan 30;61(2):243. doi: 10.3390/medicina61020243.
5
Does Sex Matter in Obesity-Induced Periodontal Inflammation in the SS Mutant Rats?性别对SS突变大鼠肥胖诱导的牙周炎症有影响吗?
Dent J (Basel). 2024 Dec 27;13(1):14. doi: 10.3390/dj13010014.
6
Association between metabolic syndrome and salivary MMP-8, myeloperoxidase in periodontitis.代谢综合征与牙周炎患者唾液基质金属蛋白酶-8、髓过氧化物酶之间的关联
Oral Dis. 2025 Jan;31(1):225-238. doi: 10.1111/odi.15014. Epub 2024 Jun 9.
7
Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis.用于阿尔茨海默病的唾液生物标志物:系统评价与荟萃分析。
Int J Mol Sci. 2024 Jan 18;25(2):1168. doi: 10.3390/ijms25021168.
牙周炎和类风湿性关节炎中中性粒细胞蛋白酶的唾液和血清水平。
Oral Dis. 2024 Apr;30(3):1660-1668. doi: 10.1111/odi.14574. Epub 2023 Apr 3.
4
Salivary Metabolomics for Systemic Cancer Diagnosis: A Systematic Review.用于系统性癌症诊断的唾液代谢组学:一项系统综述。
Metabolites. 2022 Dec 23;13(1):28. doi: 10.3390/metabo13010028.
5
Non-Canonical Functions of Myeloperoxidase in Immune Regulation, Tissue Inflammation and Cancer.髓过氧化物酶在免疫调节、组织炎症和癌症中的非经典功能。
Int J Mol Sci. 2022 Oct 14;23(20):12250. doi: 10.3390/ijms232012250.
6
Serum Myeloperoxidase as a Biomarker of Asthma Severity Among Adults: A Case Control Study.血清髓过氧化物酶作为成人哮喘严重程度的生物标志物:一项病例对照研究。
Rep Biochem Mol Biol. 2022 Apr;11(1):182-189. doi: 10.52547/rbmb.11.1.182.
7
Salivary Gland Dysfunction Secondary to Cancer Treatment.癌症治疗继发的唾液腺功能障碍。
Front Oral Health. 2022 Jun 9;3:907778. doi: 10.3389/froh.2022.907778. eCollection 2022.
8
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).关于冠状病毒病 (COVID-19) 期间免疫反应和衰竭的综合综述。
Cell Commun Signal. 2022 Jun 2;20(1):79. doi: 10.1186/s12964-022-00856-w.
9
Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review.用于口腔鳞状细胞癌诊断的唾液代谢组学:一项系统综述。
Metabolites. 2022 Mar 26;12(4):294. doi: 10.3390/metabo12040294.
10
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease.炎症性肠病生物治疗后口腔免疫唾液参数的变化
Life (Basel). 2021 Dec 16;11(12):1409. doi: 10.3390/life11121409.